AstraZeneca (AZN) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AstraZeneca sees big healthcare changes under Trump
November 10, 2016 6:56 AM ESTBy Ben Hirschler
LONDON (Reuters) - Drugmaker AstraZeneca (NYSE: AZN) expects major U.S. healthcare changes after Donald Trump's election victory but its chief executive warned on Thursday that pricing pressures in the world's biggest drugs market would not go away.
Drug stocks surged on Trump's surprise win as fears of tough action on prices subsided, given the Republican president-elect's focus on scrapping Obamacare rather than bearing down hard on drugmakers as Democrats demanded.
"Nobody knows what the new landscape will look like. It's reasonable to assume it will change substantially,"... More
Complete Donald Trump Stock Impact Guide
November 9, 2016 12:03 PM ESTDonald Trump's victory not only shocked the world but shocked the market. Below are all the sectors and stocks being impacted by his victory:
Biotech (Positive): Trump is viewed as less onerous than Clinton on drug pricing.
Gilead Sciences (NASDAQ: GILD) +4.5%Celgene (NASDAQ: CELG) +8.5%XBI (NYSE: XBI) is up 7%IBB (NYSE: IBB) is up 6.6%Alexion Pharmaceuticals (NASDAQ: ALXN)... More